Schonfeld Strategic Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,100
| Closed | -$463K | – | 2331 |
|
|
2021
Q1 | $463K | Buy |
11,100
+388
| +4% | +$16.2K | 0.01% | 1136 |
|
|
2020
Q4 | $500K | Buy |
+10,712
| New | +$500K | 0.01% | 1005 |
|
|
2018
Q2 | – | Sell |
-8,104
| Closed | -$427K | – | 1001 |
|
|
2018
Q1 | $427K | Buy |
+8,104
| New | +$427K | 0.03% | 509 |
|
|
2016
Q3 | – | Sell |
-13,135
| Closed | -$510K | – | 575 |
|
|
2016
Q2 | $510K | Buy |
+13,135
| New | +$510K | 0.11% | 221 |
|